CALC
Next report

Nov 11 2026in 34 days

EPS estimate

($1.27)

Revenue estimate

—

EPS beats

8 of last 12

EPS surprise

2024: 17.2%2024: 101.5%2024: 32.1%2024: 0.0%2025: 29.2%2025: 16.3%2025: 0.0%2025: -26.1%2026: -23.6%2026: -7.1%2026: -57.9%
Nov 9 2023Aug 11 2026
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Aug 11 2026($1.43)($2.25)-57.9%———
May 13 2026($1.40)($1.50)-7.1%———
Mar 26 2026($2.75)($3.40)-23.6%$33M——
Nov 12 2025($2.06)($2.60)-26.1%———
Aug 11 2025($2.00)($2.00)+0.0%———
May 14 2025($2.15)($1.80)+16.3%———
Mar 27 2025($0.48)($0.34)+29.2%———
Nov 13 2024($2.50)($2.50)+0.0%———
Aug 12 2024($2.65)($1.80)+32.1%———
May 13 2024($3.35)$0.05+101.5%———
Mar 28 2024($4.35)($3.60)+17.2%———
Nov 9 2023($5.70)($4.05)+28.9%———

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+173.97%
EPS—
FY2028
Rev-47.50%
EPS—
FY2029
Rev+334.29%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$2M$7M$4M$15M$20M
Low$2M$7M$4M$15M$20M
High$2M$7M$4M$15M$20M
EBITDA Avg$-9.06B$-15.91B$-7.43B$-3.60B$-4.20B
Low$-9.06B$-15.91B$-10.66B$-3.60B$-4.20B
High$-9.06B$-15.91B$-4.20B$-3.60B$-4.20B
EBIT Avg$-9.06B$-15.91B$-7.43B$-3.60B$-4.20B
Low$-9.06B$-15.91B$-10.66B$-3.60B$-4.20B
High$-9.06B$-15.91B$-4.20B$-3.60B$-4.20B
Net Income Avg$-9.06B$-15.91B$-7.43B$-3.60B$-4.20B
Low$-9.06B$-15.91B$-10.66B$-3.60B$-4.20B
High$-9.06B$-15.91B$-4.20B$-3.60B$-4.20B
EPS Avg$-3.02$-5.30$-2.48$-1.20$-1.40
Low$-3.02$-5.30$-3.55$-1.20$-1.40
High$-3.02$-5.30$-1.40$-1.20$-1.40
Analysts (Rev / EPS)4 / 23 / 22 / 21 / 11 / 1
Quarterly
MetricQ4 2026
Revenue Avg—
Low—
High—
EBITDA Avg—
Low—
High—
EBIT Avg—
Low—
High—
Net Income Avg$-4M
Low$-4M
High$-4M
EPS Avg$-1.05
Low$-1.05
High$-1.05
Analysts (Rev / EPS)— / 1

Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.